The vaccine was also 98% effective in preventing fever or breathing problems and 98.9% effective in preventing hospitalizations and death, the ministry said

There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine

Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves

As per the report, Matthew's condition has improved since his symptoms peaked on Christmas Day but still feels fatigued

This development comes hours after the UK government accepted the recommendation from the Medicines and Healthcare Regulatory Agency (MHRA) to authorise Oxford University-AstraZeneca's Covid-19 vaccine, named Covishield, for emergency use

Serum Institute of India (SII) CEO Adar Poonawalla said on December 28, that the vaccine is likely to get an emergency-use licence from the UK Medicines and Healthcare products Regulatory Agency as well as the Indian regulator, Drugs Controller General of India (DCGI), by early January

Poonawalla says Covishield shows efficacy level of 95 per cent provided two shots are taken after a gap of 2-3 months; AstraZeneca will make that public with documentation soon, he adds

The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"

The Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK before Thursday, speeding up the provision of the jab to the most vulnerable groups

Amid record coronavirus infections and deaths, Moderna has already moved vaccine supplies from its manufacturing plants to warehouses operated by distributor McKesson Corp

US President Donald Trump says: \"We've delivered a safe and effective vaccine in just 9 months. This is one of the greatest scientific accomplishments in history\"

UN Secretary-General Antonio Guterres  has said that he intends to take the COVID-19 vaccine when it becomes available and he will do so publicly, asserting that vaccination for him is a moral obligation

Albert Bourla, the CEO of Pfizer, said the company will have tiered pricing for the middle-income countries (including, India) and will give the vaccine free in Africa

In total, Britain has ordered 40 million doses of the Pfizer/BioNTech shot. As each person requires two doses, that is enough to vaccinate 20 million people in the country of 67 million

Pfizer's clarification comes as experts believe that storing the vaccine in minus 70 degree Celsius would be a big hurdle

Pfizer Inc submitted application to DCGI seeking emergency use authorisation on Dec 4; also seeks permission to import vaccine for sale and distribution in India

On December 2, the UK became the first country in the world to approve Pfizer and BioNTech coronavirus candidate BNT162b2 after the Medicines and Healthcare Products Regulatory Agency found the jab safe for widespread rollout

Confirmation of approval by National Health Regulatory Authority of Bahrain followed thorough analysis and review undertaken by authority of all available data

Study says anti-bodies declined slightly over time but remained elevated in all participants even 3 months after vaccination. NIAID director Anthony Fauci and other infectious diseases experts say it is possible that our bodies would remember virus and produce more anti-bodies if exposed to the virus again

The stock has risen 3.32% in the last 2 days of consecutive gain. Market capitalisation of the firm stood at Rs 23,994 crore today